Department of Psychosomatic Medicine and Psychotherapy, University of Göttingen Medical Centre, Göttingen, Germany.
Clinical Trial Unit of the University Medical Center Göttingen, Göttingen, Germany.
ESC Heart Fail. 2023 Jun;10(3):2051-2065. doi: 10.1002/ehf2.14294. Epub 2023 Mar 12.
Evaluation of a patient-centred biopsychosocial blended collaborative care pathway for the treatment of multimorbid elderly patients.
Healthcare interventions for the management of older patients with multiple morbidities.
Multi-morbidity treatment is an increasing challenge for healthcare systems in ageing societies. This comprehensive cohort study with embedded randomized controlled trial tests an integrated biopsychosocial care model for multimorbid elderly patients.
A holistic, patient-centred pro-active 9-month intervention based on the blended collaborative care (BCC) approach and enhanced by information and communication technologies can improve health-related quality of life (HRQoL) and disease outcomes as compared with usual care at 9 months.
Across six European countries, ESCAPE is recruiting patients with heart failure, mental distress/disorder plus ≥2 medical co-morbidities into an observational cohort study. Within the cohort study, 300 patients will be included in a randomized controlled assessor-blinded two-arm parallel group interventional clinical trial (RCT). In the intervention, trained care managers (CMs) regularly support patients and informal carers in managing their multiple health problems. Supervised by a clinical specialist team, CMs remotely support patients in implementing the treatment plan-customized to the patients' individual needs and preferences-into their daily lives and liaise with patients' healthcare providers. An eHealth platform with an integrated patient registry guides the intervention and helps to empower patients and informal carers. HRQoL measured with the EQ-5D-5L as primary endpoint, and secondary outcomes, that is, medical and patient-reported outcomes, healthcare costs, cost-effectiveness, and informal carer burden, will be assessed at 9 and ≥18 months.
If proven effective, the ESCAPE BCC intervention can be implemented in routine care for older patients with multiple morbidities across the participating countries and beyond.
一种以患者为中心的生物心理社会混合协作照护路径治疗多病共存老年患者的效果评价。
针对患有多种合并症的老年患者的医疗干预措施。
多病共存的治疗是老龄化社会医疗体系面临的日益严峻的挑战。本项综合队列研究中嵌入了一项随机对照试验,旨在测试一种针对多病共存老年患者的综合生物心理社会照护模式。
与常规护理相比,基于混合协作照护(BCC)方法并辅以信息和通信技术的整体、以患者为中心的主动式 9 个月干预措施可以改善健康相关生活质量(HRQoL)和疾病结局。
跨越六个欧洲国家,ESCAPE 正在招募患有心力衰竭、精神困扰/障碍和≥2 种合并躯体疾病的患者进入一项观察性队列研究。在该队列研究中,300 名患者将被纳入一项随机对照评估者盲法平行组干预临床试验(RCT)。在干预组中,经过培训的照护经理(CM)定期为患者及其照护者提供支持,帮助他们管理多种健康问题。CM 在临床专家团队的监督下,远程协助患者将针对其个人需求和偏好定制的治疗计划融入日常生活,并与患者的医疗服务提供者进行沟通。一个集成患者注册系统的电子健康平台可指导干预措施,并帮助赋能患者及其照护者。以 EQ-5D-5L 为主要结局指标,评估健康相关生活质量(HRQoL),次要结局指标包括医疗和患者报告结局、医疗成本、成本效益和照护者负担,分别在 9 个月和≥18 个月进行评估。
如果 ESCAPE BCC 干预被证明有效,它可以在参与国家和其他国家的多病共存老年患者常规护理中实施。